European Society for Medical Oncology (ESMO)
European Society for Medical Oncology (ESMO)
  • 469
  • 433 232
Why you should attend ESMO Asia 2024 - Prof. Cervantes
Join Prof. Andrés Cervantes, ESMO and ESMO Asia 2024 Congress President as he delves into the top reasons to attend the ESMO Asia Congress 2024, happening from 6-8 December in Singapore.
Discover the latest advancements in oncology, network with leading experts, and explore groundbreaking research. Don't miss this pivotal event!
Produced by the European Society for Medical Oncology
www.esmo.org
zhlédnutí: 30

Video

World renowned experts on why you should attend MAP 2024
zhlédnutí 16Před 4 hodinami
Top experts invite you to attend the Molecular Analysis for Precision Oncology Congress 2024. Discover the latest advancements in genomic sequencing, biomarker discovery, and personalised cancer treatments. Gain invaluable insights from leading oncologists, researchers, and industry pioneers, and be part of revolutionising patient care. Produced by the European Society for Medical Oncology www....
ESMO 2024: Join your international community in Barcelona, or Online
zhlédnutí 42Před 7 hodinami
Explore the latest advancements in oncology across various disciplines and learn from leading oncologists, researchers and healthcare professionals. An international event, hosting more than 150 countries, to ensure different perspectives are covered. Dissemination of new science, together with educational sessions, to guarantee a comprehensive and focused learning experience. A multidisciplina...
ESMO Immuno-Oncology 2024 Congress Experts in the field invite you to share your research.
zhlédnutí 46Před 7 hodinami
Thomas Powles, George Coukos, Stephen P. Schoenberger and Amanda Psyrri share their experience and highlight the benefits of sharing your research at this event: This is an event that brings clinicians and scientists together, providing a great opportunity to present your studies, discuss them and obtain valuable feedback. Here you will also have the chance to rub shoulders and share insights w...
ESMO Recommendations on clinical reporting of genomics test results for solid cancers
zhlédnutí 343Před 14 dny
Joaquin Mateo and Paul Roepman discuss the ESMO Precision Medicine Working Group recommendations on clinical reporting of genomics test results for solid cancers published in the Annals of Oncology. The recommendations based on consensus from a group of experts with different perspectives on genomics-based precision oncology, including also a patient advocate, who reviewed available evidence, c...
ESMO Immuno-Oncology 2024: Congress Experts in the field invite you to share your research.
zhlédnutí 285Před měsícem
John Haanen, Jarushka Naidoo, Kevin Harrington and Anna Maria di Giacomo highlight the benefits of sharing your research at this event: This is an event that brings clinicians and scientists together, providing a great opportunity to present your studies, discuss them and obtain valuable feedback. Here you will also have the chance to rub shoulders and share insights with key players in the fie...
ESMO Women for Oncology Forum 2023: 10 years of ESMO W4O advocating for gender equity
zhlédnutí 42Před měsícem
Last year's ESMO Women for Oncology Forum at #ESMO23 celebrated the efforts made by ESMO W4O in addressing gender-related issues facing oncology professionals, over 10 years after its establishment. Relive the moments where participants and speakers Pilar Garrido, Solange Peters, Giuseppe Curigliano, Helena Linardou, Deborah Mukherji and Thomas Powles engaged in a discussion on how to move forw...
ESMO/ASCO Global Curriculum in Medical Oncology: Insights on the 2023 Edition
zhlédnutí 83Před měsícem
Experts from the ESMO/ASCO Global Curriculum Working Group Tanja Cufer, Lidia Schapira, Jyoti Patel, and Kalijn Bol explain the importance of the ESMO/ASCO Global Curriculum and the new integrations in the latest edition from 2023. Produced by the European Society for Medical Oncology www.esmo.org
ESMO Virtual Mentorship Programme
zhlédnutí 91Před měsícem
Matteo Lambertini, Chair of the ESMO Young Oncologists Committee, and Rille Pihlak, a Committee Member, highlight the ESMO Virtual Mentorship Programme and its benefits. This 12-month programme, developed by the ESMO Young Oncologists Committee in collaboration with the ESMO Women for Oncology Committee, connects young oncologists with experienced mentors for valuable guidance and support. Part...
ESMO/ASCO Global Curriculum in Medical Oncology: Insights on the 2023 Edition
zhlédnutí 96Před měsícem
Experts from the ESMO/ASCO Global Curriculum Working Group Tanja Cufer, Lidia Schapira, Jyoti Patel, and Kalijn Bol explain the importance of the ESMO/ASCO Global Curriculum and the new integrations in the latest edition from 2023. Discover more: www.esmo.org/career-development/global-curriculum-in-medical-oncology Produced by the European Society for Medical Oncology www.esmo.org
Precision Medicine in Prostate Cancer
zhlédnutí 241Před měsícem
Elena Castro explains the biological features of prostate cancer, the impact of heterogeneity in prostate cancer and its management, the role for genomic sequencing in identifying patients with prostate cancer whose tumour exhibit actionable targets, the impact of genetic and genomic advances for the treatment of patients with prostate cancer, and how to accelerate precision medicine approaches...
#ESMO24: F. André, R. Dent, M. Garassino, M. Van der Heijden & M. Lambertini invite you to attend
zhlédnutí 132Před měsícem
Fabrice André, Rebecca Dent, Marina Garassino, Michiel van der Heijden and Matteo Lambertini share their experience at the ESMO Congress and invite you to attend. - An international event, hosting more than 150 countries, to ensure different perspectives are covered - Dissemination of new science, together with educational sessions, to guarantee a comprehensive and focused learning experience -...
ESMO Asia Congress 2024: multidisciplinary oncology in the Asian region
zhlédnutí 492Před měsícem
ESMO Asia 2024 offers a dynamic platform to share and discuss the latest research findings, clinical trials, and treatment strategies in multidisciplinary oncology, with a focus on the unique characteristics of the Asia-Pacific region. Connect with oncologists, researchers, healthcare professionals, and industry leaders. Explore scientific sessions on cutting-edge cancer research, innovative tr...
Unlock your future: Why Young Oncologists should attend MAP 2024
zhlédnutí 123Před měsícem
Sherene Loi, Fabrice André, Antoine Italiano, and Lisa Derosa invite all young oncologists to unlock their future at MAP 2024! This year’s edition of the congress constitutes a chance to explore current and emerging approaches in precision oncology, network with leading experts, and empower the next generation of oncologists. Don't miss out on this incredible opportunity to enhance your career ...
Recommendations for the use of NGS in patients with metastatic cancer
zhlédnutí 399Před měsícem
Fernanda Mosele discusses the recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group published in the Annals of Oncology. The recommendations feature the clinical impact of tumour NGS in guiding treatment decision using the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT...
Precision oncology experts on why you should submit your abstract for MAP 2024
zhlédnutí 137Před 2 měsíci
Precision oncology experts on why you should submit your abstract for MAP 2024
Why you should submit your abstract for MAP 2024
zhlédnutí 200Před 2 měsíci
Why you should submit your abstract for MAP 2024
#ESMOGynae24 A dedicated event for the gynaecological cancers community
zhlédnutí 259Před 2 měsíci
#ESMOGynae24 A dedicated event for the gynaecological cancers community
#ESMOGynae24 - R. Sanchez-Bayona and M. Kfoury share their experience at this event
zhlédnutí 90Před 3 měsíci
#ESMOGynae24 - R. Sanchez-Bayona and M. Kfoury share their experience at this event
ESMO Gynaecological Cancers Congress 2024 Members of the Scientific Committee invite you to register
zhlédnutí 133Před 3 měsíci
ESMO Gynaecological Cancers Congress 2024 Members of the Scientific Committee invite you to register
Claudia Cardone & Andreas Koulouris on how the ESMO Academy helps prepare for the ESMO Examination
zhlédnutí 118Před 3 měsíci
Claudia Cardone & Andreas Koulouris on how the ESMO Academy helps prepare for the ESMO Examination
ESMO Immuno-Oncology 2024 Congress M. Maio, A. Marabelle and I. Svane invite you to attend
zhlédnutí 175Před 3 měsíci
ESMO Immuno-Oncology 2024 Congress M. Maio, A. Marabelle and I. Svane invite you to attend
ESMO 2024: Call for abstracts from R. Stupp, J. Naidoo, J.M. Martín-Moreno, L. Siu, and J. Seligmann
zhlédnutí 430Před 4 měsíci
ESMO 2024: Call for abstracts from R. Stupp, J. Naidoo, J.M. Martín-Moreno, L. Siu, and J. Seligmann
MAP 2024: why you should attend this global congress in precision oncology
zhlédnutí 221Před 4 měsíci
MAP 2024: why you should attend this global congress in precision oncology
ESMO Summit Latin America 2024: Invitation from the ESMO President
zhlédnutí 102Před 4 měsíci
ESMO Summit Latin America 2024: Invitation from the ESMO President
ESMO 2024: A. Cervantes, R. Dent, K. Jordan & others give powerful reasons to submit your work
zhlédnutí 347Před 4 měsíci
ESMO 2024: A. Cervantes, R. Dent, K. Jordan & others give powerful reasons to submit your work
ESMO Gastrointestinal Cancers Congress 2024: An Excellent Opportunity to Network and Collaborate
zhlédnutí 352Před 4 měsíci
ESMO Gastrointestinal Cancers Congress 2024: An Excellent Opportunity to Network and Collaborate
ESMO Gastrointestinal Cancers Congress 2024: Reasons To Attend
zhlédnutí 400Před 5 měsíci
ESMO Gastrointestinal Cancers Congress 2024: Reasons To Attend
WHO-ESMO Collaboration Plan 2024-2026
zhlédnutí 231Před 5 měsíci
WHO-ESMO Collaboration Plan 2024-2026
ESMO Course in medical oncology for medical students: why should you apply?
zhlédnutí 815Před 5 měsíci
ESMO Course in medical oncology for medical students: why should you apply?

Komentáře

  • @ryanweaver962
    @ryanweaver962 Před 17 dny

    when we see vitamins and various crafting of health gain more understanding and market power... the feedback loops into populations and methodologies and value... lead reimbursements.... the interdisciplinary work and rights of individuals and groups are paramount to effective better.

  • @user-rs3lh8zt9j
    @user-rs3lh8zt9j Před 2 měsíci

    Aren't you palty Turcios

  • @marcofranzosi8825
    @marcofranzosi8825 Před 4 měsíci

    Loud music and thick French accent made this video so tough to follow

  • @stefaniecolonius4780
    @stefaniecolonius4780 Před 5 měsíci

    🎶🎵 On Wisconsin 🎵🎶 •Is there an update on the roadmap? 🤔 •Law + Healthcare 🙌🏼🙏🏼 •GAPRI Strategy 🎉 •Hospice or Home Healthcare 🤔 •Local Fellowship 🫂 🙏🏼 •Amen Juice from The Biblical Nutritionist ❤️🥳 •Medical Mushrooms • (20) Hydrocodone is not enough and that's even if it's given as a placebo. 🤯 Thank you for this video 11 years ago. Cancer Pain is a real hell experience. In advance, Id like to thank Jesus Christ for the healing that's coming. 🙏🏼 ❤ Minister Stefanie Colonius, MMHCA 💖 John 3:16 KJV 💖

  • @rittenbrake1613
    @rittenbrake1613 Před rokem

    Thank you for the teaching

  • @jessicakohgadai3852
    @jessicakohgadai3852 Před 2 lety

    I would love if you can go to Peru and treat my father from thymona cancer . He keeps getting plural in his system . 3 times water already . :(

    • @Matthouin
      @Matthouin Před rokem

      I’m looking for thymoma medicine like pill form to slow the growth . I can’t find anything type of therapy’s like that . Iv lost my left lung half my diaphragm within two years of my diagnosis ! I’m only 44

    • @zack.dar40
      @zack.dar40 Před 2 měsíci

      ​@Matthouin Matt have you looked at Coimbra protocol?

  • @1980yadalam
    @1980yadalam Před 2 lety

    very good

  • @hoahuynh5002
    @hoahuynh5002 Před 2 lety

    Very good and funny videos bring a great sense of entertainment!

  • @guilost4943
    @guilost4943 Před 2 lety

    CAN YOU PPST 1 HOU 40 MINUTES CRONIC PAIN HOW OPIATES WORKS MOST CONUN DOSAGES ON CRONIC PAIN PACIENTS OUTSIDE CANCER THIS MOST DISSEASES OPIATES USE MOST ARTITHS OSTEOARTRITHS FYBROMYALGIA LOW BACK PAIN BONE DISSEASES ETC A FULL OPIATES CRONIC PAIN PROGAM? I suffer 24 hours pain just 28 years so sad dont want continue living aoo much suffering

    • @matovicmmilan
      @matovicmmilan Před 2 lety

      Do you have access to morphine or similar analgesic where you're living?

  • @esragbilir
    @esragbilir Před 2 lety

    Thank you Prof Colombo

  • @dariotrapani1966
    @dariotrapani1966 Před 2 lety

    Immense, doc!

  • @connor6267
    @connor6267 Před 3 lety

    very cool

  • @vivianmasia2992
    @vivianmasia2992 Před 3 lety

    Thank you. This has helped a lot

  • @iangarth6174
    @iangarth6174 Před 3 lety

    A complex subject described simply! Thanks mates for a great video.

  • @neuruza
    @neuruza Před 4 lety

    I totally agree. I am a young mother and for me being able to take part in virtual meetings is sometimes much more challenging than previous, when I had to travel. I hope it will change

  • @neuruza
    @neuruza Před 4 lety

    That's true. I am 31 year old woman and a mother of 4 year old boy. I have stayed at home since March this year because of pandemic. In January i had planed to prepare my PhD thesis and some papers during this few months and imagine how many things I could not do because of this situation. I hope I will continue my work and development in the near future, however this situation had a huge impact on my career. Thank you for this video. Now I feel that somewhere in the world are great people understanding my situation. Best regards. Zuzanna

  • @ekaterinaevdo934
    @ekaterinaevdo934 Před 4 lety

    Thanks a lot! Also really grateful for ESMO colorectal cancer preceptorship in 2019, still studying and its still helpful

  • @dr.enasaboubakrelkhoulydro4703

    Valuable talk

  • @safimohammed8583
    @safimohammed8583 Před 5 lety

    As usual, You are SO GREAT our Prof

  • @AmitSehrawatdr
    @AmitSehrawatdr Před 6 lety

    Essential series is really a good initiative by ESMO, it must b made available in all sub specialities

  • @jacksalvatierra7959
    @jacksalvatierra7959 Před 6 lety

    wonderful.....

  • @shariqqayyum9660
    @shariqqayyum9660 Před 7 lety

    nice work .she is been a great researcher..

  • @johnbates2709
    @johnbates2709 Před 7 lety

    This is a great review, thank you. Great to see such a clear review of a complex rapidly evolving field that identifies the most salient areas.

  • @MuhammadKhalid-ni9fj
    @MuhammadKhalid-ni9fj Před 7 lety

    excellent symposium

  • @nicademus8
    @nicademus8 Před 10 lety

    Its nice that these new targeted drugs (BRAF inhibitors, MEK inhibitors) exist. But patient should NEVER be given them as a first-line therapy for metastatic melanoma. These drugs cannot cause complete and durable regressions of the tumors; only immunotherapies can do that. Patients should try a checkpoint inhibitor (anti-CTLA-4, anti-PD1), high dose interleukin-2, or adoptive cell transfer of infiltrating lymphocytes first. If one or more of these immune therapy attempts fail, then targeted inhibitors (BRAF, MEK) are a good fallback. These drugs can give a patient a few extra months to get their affairs in order and take a nice vacation before the melanoma inevitably becomes resistant and comes roaring back.

    • @melanomapatientnetworkeuro7910
      @melanomapatientnetworkeuro7910 Před 9 lety

      I disagree. Patients with fast-growing BRAF positive tumours might have not have the time to respond to Ipilimumab and anti-PD1 antibodies are currently not readily available first-line. IL-2 is not widely used in Europe and comes with an undesirable side effect profile. The therapeutical approach therefore needs to be tailored to the specific patient's situation and an initial salvage therapy with BRAF/MEK inhibition might provide a much better starting point for immunotherapy- giving a patient the chance to profit from the latter's long-term benefits. We need smart, undogmatic approaches how to play to the strengths of the different therapeutical groups and how to mitigate their shortcomings- like the onset of resistance with targeted therapy and the lag until first benefit associated with immunotherapies. Melanoma has the dubious honour of being one the most heterogeneous and genetically instable cancers making one-size-fits-all therapeutical approaches very unlikely to work.

  • @artlabagnata
    @artlabagnata Před 10 lety

    Eccelente intervento dell'amico Caraceni. Grazie. Difondiamo con piacere.

  • @altawhite1699
    @altawhite1699 Před 10 lety

    :)